When lymph nodes are removed or damaged during breast cancer treatment, it can result in painful and debilitating swelling. This condition is known as lymphedema, and experts estimate that from 20% to 30% of women will experience some level of lymphedema after breast cancer surgery or radiation.
Currently, Medicare and many private insurance policies fail to cover the costs of the daily compression supplies people with lymphedema need to control their swelling. People who can’t afford these supplies are left with worsening lymphedema, which can lead to infections and even long-term disability.
The Lymphedema Treatment Act would end this injustice by changing Medicare law to cover compression supplies—setting an important precedent for Medicaid and other insurers to do the same.
All women deserve access to comprehensive lymphedema treatment. Write and call your legislators and tell them to cosponsor the Lymphedema Treatment Act.
Photo, left to right: Bethany Zell, MBCC President; Jaclyn Silk, Bangor Savings Bank Assistant Vice President and branch manager of the State Street branch; Carol Beagan, MBCC Treasurer.
MBCC President Bethany Zell wrote, "Breast Cancer Deadline 2020® is the National Breast Cancer Coalition's global initiative to know how to end breast cancer by January 1, 2020. As leaders in the breast cancer movement and supporters of Breast Cancer Deadline 2020®, we are committed to being a part of this important work."
Photo: MBCC volunteer Gail Murphy, fundraiser coordinator; Matt Howe, owner of of Sushi Maine